BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1503573)

  • 1. [Dependence of anti-acetylcholinesterase effectiveness of phosphoorganic inhibitors on the accessibility of the phosphorus atom].
    Shestakova NN; Rozengart EV; Zhorov BS
    Bioorg Khim; 1992 Apr; 18(4):596-603. PubMed ID: 1503573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational differences in the sorption of choline ligands at the active site of acetylcholinesterase].
    Shestakova NN; Rozengart EV
    Bioorg Khim; 1995 May; 21(5):323-9. PubMed ID: 7661856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between the anticholinesterase effect of organophosphorous inhibitors and the extent of shielding (accessibility) of the phosphorus atom.
    Rozengart EV
    Dokl Biochem Biophys; 2003; 389():130-3. PubMed ID: 12856422
    [No Abstract]   [Full Text] [Related]  

  • 5. Decalin-type acetylcholine-mimetic organophosphates as inhibitors of acetylcholinesterase.
    Furegati S; Gorla F; Linden A; Rüedi P
    Chem Biol Interact; 2005 Dec; 157-158():415-7. PubMed ID: 16429565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conformation-functional relations in oligomethylenesulfone organophosphorus inhibitors of cholinesterases of various origin].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1998; 34(5):563-9. PubMed ID: 10198993
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
    Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
    J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of the enantiomerically pure cis- and trans-2,4-dioxa-3-fluoro-3-phosphadecalins as inhibitors of acetylcholinesterase.
    Wächter M; Rüedi P
    Chem Biodivers; 2009 Mar; 6(3):283-94. PubMed ID: 19319864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
    Ekström F; Akfur C; Tunemalm AK; Lundberg S
    Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective interaction with acetylcholinesterase of an organophosphate insecticide fenamiphos.
    Wang C; Zhang N; Li L; Zhang Q; Zhao M; Liu W
    Chirality; 2010 Jun; 22(6):612-7. PubMed ID: 19899158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of individual phospholipid fractions in the brains of rats poisoned by phosphoorganic cholinesterase inhibitors].
    Dvorkin VIa; Kiselev GV
    Biull Eksp Biol Med; 1972 Nov; 73(11):51-3. PubMed ID: 4345588
    [No Abstract]   [Full Text] [Related]  

  • 12. Research into selective biomarkers of erythrocyte exposure to organophosphorus compounds.
    Aminoff D; Bochar DA; Fuller AA; Mapp AK; Showalter HD; Kirchhoff PD
    Anal Biochem; 2009 Sep; 392(2):155-61. PubMed ID: 19497294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and affinity constants of the inhibition of brain acetylcholinesterase by organophosphorus anticholinesterases.
    Awad O; Gabr Y; Osman M
    Arzneimittelforschung; 1972 Jun; 22(6):1035-7. PubMed ID: 5068351
    [No Abstract]   [Full Text] [Related]  

  • 14. New bisphosphorothioates and bisphosphoroamidates: synthesis, molecular modeling and determination of insecticide and toxicological profile.
    dos Santos VM; Sant'Anna CM; Moya Borja GE; Chaaban A; Côrtes WS; DaCosta JB
    Bioorg Chem; 2007 Feb; 35(1):68-81. PubMed ID: 17055030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The generalized mechanism of the irreversible inhibition of cholinesterase activity by organophosphorus inhibitors].
    Agabekian RS; Liubimov VS
    Dokl Akad Nauk SSSR; 1991; 318(2):459-66. PubMed ID: 1893839
    [No Abstract]   [Full Text] [Related]  

  • 17. Species specificity in the chemical mechanisms of organophosphorus anticholinesterase activity.
    Wallace KB; Kemp JR
    Chem Res Toxicol; 1991; 4(1):41-9. PubMed ID: 1912299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin.
    Martin BP; Vasilieva E; Dupureur CM; Spilling CD
    Bioorg Med Chem; 2015 Dec; 23(24):7529-34. PubMed ID: 26585276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase.
    Masson P; Gouet P; Clery C
    J Mol Biol; 1994 May; 238(3):466-78. PubMed ID: 8176737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase.
    Carolan CG; Gaynor JM; Dillon GP; Khan D; Ryder SA; Reidy S; Gilmer JF
    Chem Biol Interact; 2008 Sep; 175(1-3):293-7. PubMed ID: 18571631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.